Favorable outcome of ex‐vivo purging of monocytes after the reintroduction of treatment after interruption in patients infected with multidrug resistant HIV‐1
Hamid Hasson(Vita-Salute San Raffaele University), Alberto Beretta, Barbara Mantelli(Mario Negri Institute for Pharmacological Research), Mauro Malnati(Vita-Salute San Raffaele University), Silvia Nozza(IRCCS Ospedale San Raffaele), Massimo Cernuschi(Vita-Salute San Raffaele University), Mario Clerici(University of Milan), Andrea Vecchi(Fundación Mutua Madrileña), Nicola Gianotti(Vita-Salute San Raffaele University), Adriano Lazzarin(Vita-Salute San Raffaele University), Enzo Boeri(National Cancer Institute), Priscilla Biswas(Mario Negri Institute for Pharmacological Research)
Cited by 6
Related Papers
The chemokine system in diverse forms of macrophage activation and polarization
|Trends in Immunology|2004|6.5k
Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022
|New England Journal of Medicine|2022|2.2k
Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and Australia
|New England Journal of Medicine|2003|653
In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression
|Nature Medicine|1997|635